An international expert in the financing and growth of high tech businesses LinKinVax, a clinical-stage biotechnology company specializing in the treatment of infectious diseases and certain forms
TO ACCELERATE THE DEVELOPMENT OF ITS INNOVATIVE VACCINE PLATFORM LinKinVax, a clinical-stage biotechnology companyis announcing completion of a €4.350 million seed capital funding round. It was led
LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of